Core Scientific (CORZ) Capital Expenditures (2021 - 2026)

Core Scientific has disclosed Capital Expenditures across 6 years of filings, most recently posting $565.0 million for Q2 2026.

• In Q2 2026, Capital Expenditures rose 365.88% year-over-year to $565.0 million; the TTM figure through Jun 2026 stood at $1.5 billion (up 457.33% YoY), while the FY2025 annual figure was $729.0 million, up 667.68% from the prior year.
• Capital Expenditures came in at $565.0 million for Q2 2026 at Core Scientific, up from $389.2 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $565.0 million in Q2 2026 to a low of $235000.0 in Q2 2023.
• Average Capital Expenditures over 5 years is $121.0 million, with a median of $57.9 million recorded in 2024.
• Year-over-year, Capital Expenditures plunged 99.78% in 2023 and jumped 3768.55% in 2025.
• Over 5 years, Capital Expenditures stood at $140.2 million in 2022, then slumped by 91.7% to $11.6 million in 2023, then jumped by 146.96% to $28.8 million in 2024, then jumped by 871.03% to $279.2 million in 2025, then soared by 102.34% to $565.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $565.0 million in Q2 2026, $389.2 million in Q1 2026, and $279.2 million in Q4 2025.